Allergex
Non Drowsy Syrup Loratadine 150ml
Contains active ingredients including Loratadine .
Pharmacy collection
This product is available for collection at a Clicks pharmacy only.
Dispensed by pharmacist
Dispensed at the professional discretion of a Clicks Pharmicist
Find in-store
See if we have this item in your closest store
pharmacy collection
This product is available for collection at a Clicks pharmacy only.
dispensed by pharmacist
Dispensed at the professional discretion of a Clicks Pharmicist
More Information
Detailed information
Description:
Allergex Non Drowsy Syrup Loratadine 150ml
Detailed Description:
Composition:
Each 5ml of Allergex non drowsy syrup contains:
Loratadine (micronised) - 5mg.
Preservative:
Sodium benzoate - 0.1% m/v.
Contains sugar:
Sucrose - 1 000 mg.
Pharmacological classification:
A: 5.7.1 Antihistaminics.
Pharmacological action:
Loratadine is a long acting piperidine antihistamine. It is a selective H,-receptor antagonist, which is a reversible, competitive inhibitor of histamine at H,-receptor sites.
Loratadine is a second generation (non-sedating) H,-receptor antagonist.
Following oral administration, peak plasma concentrations are achieved in 2 to 3 hours. Loratadine is metabolised in the liver to active metabolites by the hepatic microsomal P450 system.
It does not cross the blood brain barrier.
Identification:
Allergex non drowsy syrup is a clear, colourless syrup having a characteristic peach odour and taste.
Presentation:
Amber glass bottles of 100 ml and 150 ml syrup.
www.adcock.com.
Relief of symptoms associated with:
Seasonal allergic rhinitis.
Chronic spontaneous urticaria.
5ml = 1 medicine measure.
Each 5ml of syrup contains:
Loratadine (micronised) - 5mg.
Preservative: sodium benzoate 0.1% m/v.
Contains sugar: sucrose - 1 000mg.
Pack size:
150ml
Quantity in pack:
1
Marketing description:
S2.
Allergex®.
Non drowsy syrup.
Loratadine.
Once daily.
For allergies in children.
Adcock Ingram.
Brand:
Allergex
Package type:
Box
How to use
Usage instructions:
Dosage and directions for use:
Children 2 to 5 years of age: 5ml (1 medicine measure) once daily.
Children 6 to 12 years of age: 10ml (2 medicine measures) once daily.
Adults and children 12 years of age and over: 10ml (2 medicine measures) once daily.
The use of Allergex non drowsy syrup should be limited to 14 days.
Dosage and directions for use:
Children 2 to 5 years: 5ml once daily.
Children 6 to 12 years: 10ml once daily.
Adults and children 12 years and over: 10ml once daily.
Storage instructions:
Store in a well-closed container below 25 degrees C. Protect from light.
Warnings:
Indications:
The relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhoea, and itching of nose and throat.
Allergex non drowsy syrup is also indicated for the relief of chronic idiopathic urticaria and other allergic dermatoses.
Contraindications:
Allergex non drowsy syrup is contraindicated in individuals who have shown hypersensitivity to any of its ingredients.
Safety in pregnancy and lactation has not been established.
The safe use of Allergex non drowsy syrup in children under 2 years of age and in the elderly has not been established.
Side effects and special precautions:
Side effects:
Gastrointestinal side effects including nausea, vomiting, diarrhoea or epigastric pain have been reported. Fatigue, headache, somnolence and dry mouth have also been reported.
Allergic symptoms like rashes and hypersensitivity reactions may occur.
Sedation and nervousness have been reported.
Abnormal hepatic function has also been reported less frequently.
Palpitations and arrhythmias have been reported.
Blood disorders including agranulocytosis, leucopenia, haemolytic anaemia and thrombocytopenia, although less frequent, have been reported.
Convulsions, sweating, myalgia, paraesthesia, extrapyramidal effects, tremor, sleep disturbances, depression, tinnitus, hypotension, and hair loss have been reported.
Photosensitivity may occur.
Precautions:
Allergex non drowsy syrup lacks significant sedative properties. However, patients should be advised that a small number of individuals may experience sedation. Therefore, the effect of the medicine on a particular patient should be ascertained before they can drive or operate machinery. Patients with hepatic impairment should be administered a reduced dose as they may have decreased clearance of loratadine; an initial dose of 5ml once daily or 10ml on alternate days is recommended.
Use with caution in patients with epilepsy due to less frequent reports of convulsions.
Cross sensitivity to related drugs may occur.
Drug/laboratory test interactions:
The use of Allergex non drowsy syrup should be stopped approximately 48 hours before skin testing as antihistamines may suppress the positive skin response to allergen extracts.
Drugs known to inhibit the hepatic metabolism of loratadine include cimetidine, erythromycin, ketoconazole, quinidine, fluconazole and fluoxetine. These drugs should therefore not be administered concomitantly with loratadine as they may raise the plasma concentrations of loratadine. However, no clinically significant consequences have been observed when these drugs are administered concomitantly.
Known symptoms of overdosage and particulars of its treatment:
See "side effects and special precautions".
Cardiac effects such as tachycardia have been reported.
Headache and somnolence have also been reported with overdoses.
In the event of overdosage, treatment should be started immediately.
Treatment is symptomatic and supportive.
Haemodialysis is not an effective means of removing loratadine or its metabolites from the body.
The effects of the medicine should be established before individuals drive or operate heavy machinery.
Not for children under 2 years.
The use of Allergex non drowsy syrup should be limited to 14 days.
Allergex non drowsy syrup lacks significant sedative properties. However, a small number of individuals may experience sedation that may be aggravated by the simultaneous intake of alcohol or other central nervous system depressants.
Keep out of reach of children.